Eletriptan

CHEMBL1510 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
382.5 g/mol
LogP
4.1
Phase
4

This medication works by narrowing blood vessels in the brain and blocking pain signals to relieve migraine headaches. It is taken at the first sign of a migraine to reduce headache severity and associated symptoms.

분자량

382.5000 g/mol

LogP

4.10

TPSA

61.60 Ų

리핀스키 5의 법칙

통과

치료 영역

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12

InChI

InChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1

Molecular Formula

C22H26N2O2S

HBD / HBA

1 / 3

회전 가능 결합

6

무거운 원자

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

This medication works by narrowing blood vessels in the brain and blocking pain signals to relieve migraine headaches. It is taken at the first sign of a migraine to reduce headache severity and associated symptoms.

Yes, Eletriptan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1510. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 77993. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.